SVA Share Price

Open 0.22 Change Price %
High 0.22 1 Day 0.00 0.00
Low 0.22 1 Week 0.00 0.00
Close 0.22 1 Month -0.02 -8.33
Volume 46000 1 Year -0.06 -21.43
52 Week High 0.38
52 Week Low 0.18
SVA Important Levels
Resistance 2 0.22
Resistance 1 0.22
Pivot 0.22
Support 1 0.22
Support 2 0.22
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
FTI 0.25 150.00%
FTI 0.25 150.00%
BVQ 0.02 100.00%
VR 0.02 100.00%
VR 0.02 100.00%
DDX 0.50 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
AAT 0.04 100.00%
AAT 0.04 100.00%
More..
CVE Canada Top Losers Stocks
CPC 0.00 -100.00%
LTX 0.00 -100.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Sernova Corp (CVE: SVA)

SVA Technical Analysis 4
As on 26th Jun 2017 SVA Share Price closed @ 0.22 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.27 & Sell for SHORT-TERM with Stoploss of 0.24 we also expect STOCK to react on Following IMPORTANT LEVELS.
SVA Target for June
1st Target up-side 0.25
2nd Target up-side 0.27
3rd Target up-side 0.28
1st Target down-side 0.21
2nd Target down-side 0.19
3rd Target down-side 0.18
SVA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.sernova.com
SVA Address
SVA
700 Collip Circle
Suite 114
London, ON N6G 4X8
Canada
Phone: 519-858-5184
Fax: 519-858-5099
SVA Latest News
Active Runner in Focus: Sernova Corp (SVA.V)   Concord Register   - 26th Jun 17
Sernova Corp. (SVA) Analysts See $0.00 EPS, Schmitt Industries (SMIT ...   UtahHerald.com   - 21st Jun 17
Sernova Corp. (SVA) Analysts See $0.00 EPS   WeeklyHub   - 16th Jun 17
Sernova Corp. (SVA) EPS Estimated At $0.00   Weekly Register   - 14th Jun 17
Analysts See $0.00 EPS for SERNOVA CORP COM NPV (SEOVF)   Weekly Register   - 05th Jun 17
Sernova Provides Company Outlook on Corporate and Clinical Developments   Marketwired (press release)   - 05th Jun 17
Sernova Receives Approval to Extend Term of Warrants   Marketwired (press release)   - 05th May 17
Sernova Announces Appointment of New CFO   Marketwired (press release)   - 30th Sep 16
JDRF backs Sernova's implant for T1D   Mass Device   - 08th Sep 16
Sernova Receives Issued Patent in the United States for Its Cell Pouch™ and ...   Marketwired (press release)   - 23rd Apr 15
Interactive Technical Analysis Chart Sernova Corp ( SVA CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sernova Corp
SVA Business Profile
Sernova Corp., a clinical-stage health sciences company, focuses on the development and commercialization of medical technologies. The company’s proprietary platform technologies include Cell Pouch System, a scalable device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. It also intends to commercialize the products for parkinson’s, spinal cord injury, and haemophilia diseases. The company is headquartered in London, Canada.